Ally Speight is a consultant gastroenterologist and IBD lead at the Newcastle upon Tyne NHS trust. He is a graduate of Girton College, Cambridge (Natural Sciences, Genetics) and completed his MBBS, with honours, at Newcastle University in 2005. He completed specialty training in gastroenterology in North East England. He subspecialises in IBD and was awarded an MD by Newcastle University for his research in metabolic signalling pathways in Crohn’s disease in 2015. He has a clinical interest in IBD, coeliac disease and GI complications from oncology treatments. His research interests include therapeutics in IBD and IBD associated cancers. He is a PI on several commercial trials and investigator led, portfolio studies in IBD. He was awarded an NIHR Greenshoots award in 2017. He is a member of the BSG IBD Committee and has helped draft the BSG position statement on both immune inhibitor checkpoint colitis and also monogenic IBD.